This content is machine translated Leukemic cutaneous T-cell lymphoma (L-CTCL) Sézary syndrome and mycosis fungoides: STAT5 as a therapeutic target? As the disease progresses, the tumor cells in leukemic variants of cutaneous T-cell lymphomas spread not only in the skin but also in the blood and lymph nodes. Although an…
View Post 11 min This content is machine translated Aggressive lymphomas Therapy in everyday clinical practice based on current developments Lymphoma accounts for 3.8% of all new cancer diagnoses. According to the current WHO classification, there are over 75 different lymphomentities, which are treated differently. In the treatment of diffuse… CME-Test
View Post 4 min This content is machine translated Hodgkin's lymphoma Overview of current therapeutic approaches Hodgkin’s disease belongs to the group of malignant lymphomas and is manifested by painless swelling of the lymph nodes, which are very often initially found on the neck or behind…
View Post 10 min This content is machine translated Pruritus - How to treat? The recommendations of the new AWMF guideline chronic pruritus In order to treat pruritus adequately, the cause of the itching should be known. The clinical pruritus classification of the International Forum for the Study of Itch (IFSI) distinguishes three…
View Post 3 min This content is machine translated News from the ASH Congress on Nivolumab High response rates even in pretreated Hodgkin’s lymphomas Preclinical studies show that Sternberg-Reed cells, characteristic of classical Hodgkin lymphoma, use the PD-1 pathway to evade immunodetection. Therefore, immune checkpoint inhibitors such as nivolumab, which binds to the PD-1…
View Post 4 min This content is machine translated Hodgkin's lymphoma Avoiding unnecessary chemotherapy cycles and radiation with PET? At the annual meeting of the German, Austrian and Swiss Societies of Hematology and Medical Oncology (DGHO), various questions regarding the care of patients with Hodgkin’s lymphoma were controversially discussed.What…
